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ABSTRACT: The mammalian odorant receptors (ORs) form a
chemical-detecting interface between the atmosphere and the
nervous system. This large gene family is composed of hundreds
of membrane proteins predicted to form as many unique small
molecule binding niches within their G-protein coupled receptor
(GPCR) framework, but very little is known about the molecular
recognition strategies they use to bind and discriminate between
small molecule odorants. Using rationally designed synthetic
analogs of a typical aliphatic aldehyde, we report evidence that
among the ORs showing specificity for the aldehyde functional
group, a significant percentage detect the aldehyde through its
ability to react with water to form a 1,1-geminal (gem)-diol.
Evidence is presented indicating that the rat OR-I7, an often-studied and modeled OR known to require the aldehyde function of
octanal for activation, is likely one of the gem-diol activated receptors. A homology model based on an activated GPCR X-ray
structure provides a structural hypothesis for activation of OR-I7 by the gem-diol of octanal.
The mammalian nose is a chemistry−biology interface.Odorant molecules are detected there by specialized cells
known as olfactory sensory neurons (OSNs).1,2 Each OSN
expresses on its surface a single member of the odorant
receptor (OR) family, so that the pharmacologic odorant
response of the OSN is determined by the OR it expresses.3,4
The ORs make up the largest family of G-protein coupled
receptors (GPCRs) in the mammalian genome. Rodent
genomes, for example, are predicted to encode ≈1100
functional ORs,5−7 while in humans about half of the ≈800
GPCRs are odorant receptors.8 Each membrane-bound OR has
a different primary sequence, and each is expected to form a
unique small-molecule binding niche within the GPCR
structural framework. Fewer than 10% of the mouse and
human ORs have been matched with an odorant agonist,9 and
to date, no olfactory GPCR crystal structures have been solved.
The small molecule recognition and discrimination strategies
used in mammalian olfaction are therefore largely unexplored.
Understanding the molecular details of odorant binding and
functional group discrimination by the ORs (i) will improve
our understanding of membrane protein−small molecule
recognition, (ii) may reveal new strategies for targeting
nonolfactory GPCRs of therapeutic interest, and (iii) could
lead to high-affinity ligands able to promote the crystallization
of odorant-bound GPCRs for pioneering structural studies.
Until OR X-ray crystal structures become feasible, less direct
approaches such as structure−activity relationships, muta-
genesis studies, and computational modeling continue to be
needed.10
The aldehyde functional group is common among natural
product odorants and synthetic fragrances.11 Although to reach
the ORs an odorant must first dissolve in the water-based
mucus covering the OSN tissue, the possibility that the
hydrated form of the aldehyde, that is, the 1,1-geminal-diol or
gem-diol (Scheme 1), is the activating ligand for some aldehyde-
specific receptors has, to our knowledge, not been investigated.
The lack of experimental OR structural information has
prompted many computational OR studies, several of which
have been carried out on aldehyde-binding ORs. In particular,
of the 20 studies we found where at least one OR-odorant
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complex was computationally modeled, 14 (64%) included the
modeling of an aldehyde in its carbonyl form.10,12−24 Clearly, to
obtain the most accurate results, it is important to know the
physiologically active form of the odorant.
Hydration of an aldehyde to its corresponding gem-diol
dramatically changes the steric and electronic environment
around the aldehyde carbon (C-1). First, the geometry
rearranges from planar (sp2) to tetrahedral (sp3), reorienting
the polar covalent bonds at C-1 (Scheme 1). Second, the
hydrogen (H)-bonding capabilities near C-1, which likely play a
role in binding aldehyde-specific ORs, are tripled, creating two
new H-bond donors and two new acceptor lone pairs, while
reorienting the initial two H-bond acceptor pairs. Third, while
the net molecular dipoles likely do not differ greatly between
the two forms, the individual C−O σ bond dipoles of the gem-
diol are weaker and reoriented. Fourth, the gem-diol of an
aldehyde can be more extensively solvated than the aldehyde
form, making it more amphipathic, a difference that may affect
activation by changing the kinetics of entering and leaving the
binding niche, or by allowing water molecules to mediate
recognition. Overall, hydration changes the aldehyde functional
group to such an extent that, among those ORs that are specific
for, that is, narrowly tuned to, the aldehyde functional group, it
is unlikely that a single activated receptor conformation would
recognize and be stabilized by both forms. This idea raises the
possibility that for some aldehyde-specific ORs, the aldehyde
group may be discriminated from other H-bond accepting
functional groups by virtue of its ability to undergo chemical
transformation to the gem-diol prior to encountering, or once
within, the OR.
In this study, we have aimed to understand the true chemical
nature of an activating aldehyde odorant, first among a large
collection of rat ORs activated by a common fragrant aldehyde,
octanal, and then for a well characterized OR whose activation
is known to be rigorously aldehyde-specific. We present
pharmacologic evidence supporting the conclusion that
among the ORs activated by octanal, approximately 11% are
activated by the less volatile but more H-bond-rich octane-1,1-
diol. Surprisingly, within the subset of octanal-activated ORs
that show specificity for the aldehyde functional group
compared to its corresponding alcohol, nearly half appear to
be activated by the gem-diol, raising the possibility that carbonyl
hydration is a common determinant of aldehyde discrimination.
■ RESULTS AND DISCUSSION
A Strategy to Detect Gem-Diol Dependent Receptor
Activation. Our hypothesis is that some ORs appearing to
recognize the aldehyde functional group are in fact activated by
the gem-diol. To test this hypothesis, our approach is to
manipulate the hydration equilibrium constant for a typical
aldehyde through derivatization and then to compare the
activity of the derivatized and natural compounds on live rat
OSNs. The equilibrium hydration constant for n-aldehydes
(Khyd) is ≈0.83 (25 °C; 0.62 at 35 °C) (Scheme 1).
25,26 Highly
electronegative groups such as fluorine on carbon 2 (C-2) upset
this equilibrium and lead to near-complete hydration, with for
example an estimated Khyd of 4500 (20 °C) for 2,2-
difluorononanal.27 We selected octanal to represent a typical
aliphatic aldehyde odorant and 2,2-difluorooctanal to represent
its fully hydrated form (Scheme 1). We chose octanal because it
is a structurally simple, frequently studied aldehyde odorant
that activates a large number (≈70 at 30 μM) of different
rodent OR family members,28−31 and because it is the primary
natural product odorant for the well characterized rat OR-I7
receptor, which is known to require the aldehyde functional
group for binding and activation.31,32
Fluorine is strongly electronegative and, with a van der Waals
radius of 1.47 Å, only slightly larger than hydrogen (1.2 Å).33
These characteristics should maximize the electronic effect on
hydration while minimizing confounding steric effects. To avoid
a chirality center at C-2 and the well-known instability of α-
monofluoro aldehydes,34 we limited our study to 2,2-difluoro
Scheme 1. Aldehyde Hydration Equilibria and H-Bonding
Capability
Figure 1. Octanal and structural analogs used to screen rat olfactory sensory neurons for activation by the gem-diol of octanal. Electrostatic potential
maps were calculated using Spartan 10 V1.1.0.
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substitution. Beyond altering the hydration behavior, difluoro-
substitution can cause other changes and some of these may
affect OR binding and activation. For instance, the fluorines
introduce two bond dipoles at C-2, and these may dominate the
receptor interaction for some ORs apart from the hydration
effect. However, since we consider only the subset of cells (and
therefore ORs) activated by octanal, ORs responding chiefly to
the C−F dipoles will be disregarded because octanal does not
contain C−F bonds and most octanal ORs should not be
activated directly by them. Moreover, as described in detail
below, compound 4 provides an additional control to filter out
ORs whose activation depends primarily on fluorine sub-
stitution at C-2.
We chose the four additional compounds shown in Figure 1
to interrogate a large sampling of rat octanal ORs for evidence
of octane-1,1-diol recognition. We reasoned that cells
expressing octanal receptors requiring the gem-diol will respond
to octanal 1, which at equilibrium forms ≈40% of the gem-diol
and, for those ORs where the fluorines do not interfere, to the
2,2-difluoro analog 2, which forms >99.9% of the gem-diol.
However, the corresponding alcohols, 2,2-difluorooctanol 4 and
1-octanol 5, will not activate octanal ORs that require the
second hydroxyl of the gem-diol. We thus look for cells whose
activation hinges upon the presence of the geminal hydroxyls.
Using compound 4 as a control reduces the chances of false
positives due to the C−F bond dipoles introduced by using
fluorine. For example, consider a cell expressing the rare OR
activated by octanal in its carbonyl form, but that also happens
to respond to the dipoles of fluorine substitution. The response
of such a cell could be dominated by the dipoles to the extent
that it is also activated by 2, which forms a negligible amount of
the carbonyl, thereby giving a false positive. However,
activation of an octanal receptor by 4 would alert us to the
possibility that the C−F dipoles are contributing directly to the
activation of that OR, and information from that cell would not
be taken as evidence for gem-diol recognition. Compound 3,
2,2-dimethyloctanal, serves as a control compound with an
inverse inductive effect which should suppress gem-diol
formation compared to octanal. Though methyl groups are
the smallest electron-releasing groups we can use, they are
significantly larger than H and F, and might for steric reasons
fail to activate some of the ORs that require the aldehyde
carbonyl (i.e., false negatives for carbonyl form). We also
considered including octanoic acid in the list of control
compounds, but a previous study in rat OSNs reported that
90% of octanal-responding cells that failed to respond to
octanol also failed to respond to octanoic acid.35 To minimize
the number of test compounds, and therefore maximize the
number of cells remaining functional until the end of the assay,
it was not included. Overall, in a particular cell, comparably
strong activation by compounds 1 and 2, with no activation
from compounds 3, 4, and 5 will constitute a pharmacologic
signature for gem-diol-specific ORs, and allow us to assess the
prevalence of this OR strategy for recognizing the aldehyde
functional group. As described above, our approach seeks to
minimize false positives resulting from the fluorine substituents,
that is, carbonyl-specific cells that appear to be activated by the
gem-diol, but false negatives are unavoidable and prevent us
from making a complete tally of the carbonyl-specific versus
gem-diol-specific octanal ORs. False negatives include gem-diol
specific ORs unable to accommodate the two fluorines on
compound 2 because they are too large, or incompatibility with
the dipoles, and carbonyl-specific ORs unable to accommodate
the two methyls of compound 3. The synthesis of compounds
2−4 is outlined in Scheme 2. Experimental details can be found
in the Supporting Information.
Aldehyde Hydration Equilibria and α-Substitution.
Prior to biological testing, we studied aldehydes similar to 1−3
by 1H NMR to verify the hydration change between n-alkanals
and the corresponding 2,2-disubstituted analogs (Table 1; see
Supporting Information for full spectra). Due to the low
solubility of octanal in water, we compared the shorter
congeners hexanal, 2,2-dimethylhexanal, and 2,2-difluorohepta-
nal. The aldehyde Khyd has been found elsewhere to be
unaffected by the number of carbons in an n-alkyl chain.25 The
Khyd (23 °C) changed from ≈0.75 for hexanal to ≈5000 for
difluoroheptanal. In contrast, 2,2-dimethylhexanal formed no
detectable gem-diol.
Octanal Analog Screening in Live Olfactory Sensory
Neurons. We used calcium imaging recordings4,28 to profile
1053 functional OSNs following dissociation of the cells from
the rat olfactory epithelium and mucus. Since OSNs express a
single OR family member,3,4 single-cell activity can be taken to
represent a single OR’s response to each of compounds 1−5. In
this technique, the OSNs are first loaded with the calcium
sensitive fluorescent dye Fura-2 and then exposed to 30 μM
ligand solutions in a flow-through perfusion chamber fitted
onto a fluorescence microscope. The short lifetime of the
dissociated OSNs limits the number of tests that can be done
on dissociated OSNs, so we relied on a single concentration
that was previously found to be conducive for detecting low
and high affinity ORs and for detecting functional group
selectivity in OSNs.35 Compounds functioning as agonists
activate signal transduction within the cells, leading rapidly to
depolarization-driven calcium influx and a reduction of
fluorescence at the monitored wavelength. Thus, optical
monitoring of the dispersed cells permits the screening of
many OSNs while retaining single-cell, and therefore single OR
family member, resolution.
Scheme 2. Synthetic Routes to Compounds Used in Odorant
Receptor Testing and NMR Hydration Study
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The fluorescence trace of a representative octanal-activated
cell is shown in Figure 2a, and a summary of the responses of
all octanal-activated cells to the screening compounds is shown
in Figure 2b. Responses for each compound are reported
relative to the octanal response generated by that cell, which is
set to 100% (red in color scale), and the cells are grouped
according to similarity of response. Out of 1053 cells, 87 cells
(8%, Figure 2b, c1−c87) were activated by octanal and then
observed for their response to compounds 2−5. These cells
exhibited 59 unique response patterns when the scaled
measurements were taken into account, suggesting the presence
of a large variety of OR binding niches differentially affected by
this group of close analogs. Substitution at C-2 was generally
unfavorable for octanal OR activation. Only 28% of octanal-
activated cells were activated by 3, and 52% were activated by
2. This trend argues that the loss of activation of these ORs is
more steric than electronic, as the smaller fluorine substituent
was better tolerated. This experimentally verified bias against C-
2 substitution increased our expectation that there would be
some false negatives, that is, aldehyde-specific ORs that our
approach would not be able to identify as either carbonyl- or
gem-diol-specific.
Octanal and octanol are natural products that differ only by
the oxidation state at C-1. Of the 87 cells activated by octanal,
Table 1. Hydration Equilibrium of Aldehydes Measured by 1H-NMR in D2O at 23 °C
Figure 2. Calcium imaging results for olfactory sensory neuron responses to compounds 1−5. (a) A representative calcium imaging trace, here
depicting the cell c35 response. Broken line shows the octanal trend-line over the course of the experiment (see Methods). Small squares summarize
the fluorescence response normalized to that of octanal, according to color scheme shown in panel b. The tick mark below each compound number
marks the start of the 4 s injection of odorant solution into buffer stream flowing over cells. (b) Summary of responses for all octanal-activated cells
to compounds 1−5 at 30 μM. (na, no data). Fluorescence changes are normalized to each cell’s response to compound 1, which is set to 100%.
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59 cells (68%; Figure 2B, c13−c26, c41−c70, c73−c87) were
also activated by octanol. The ORs expressed in these cells
failed to distinguish between octanal and octanol and are
therefore not aldehyde group-specific octanal ORs. In contrast,
24 cells (28%, c1−12, c27−37, c71) were activated by octanal
but not by alcohols 4 or 5. These cells express ORs appearing
to require the aldehyde group for activation. The remaining
≈4% of cells (c38−40, c72) were activated by difluoro alcohol
4 but not by octanol 5. Of these cells, c38−39 appear to have
some affinity for the fluorine substituents or their dipoles, and
thus, we do not assign them to the gem-diol specific category
even though they are strongly activated by gem-diol 2.
The 24 cells appearing to require the aldehyde for activation
by octanal fell into four subgroups: those stringently specific for
octanal and responding to no other analog (50%, c1−12);
those producing the pharmacologic pattern consistent with a
requirement for the gem-diol (42%, c27−36; 11% of all octanal-
activated cells); one cell producing the pharmacologic pattern
consistent with a requirement for the carbonyl form (4%, c71);
and one indeterminate cell appearing to require the gem-diol,
but also activated by 2,2-dimethyloctanal (4%, c37). Assuming
the aldehyde is recognized as either the carbonyl or gem-diol,
cells c1−12 could be false negatives for either carbonyl- or gem-
diol-specific ORs, but we cannot assign them to either category.
The data from cells c27−36 support the surprising conclusion
that, among aldehyde-specific cells, about 42% (10/24)
appeared to require the gem-diol. Thus, recognition of the
gem-diol may be a common means to discriminate the aldehyde
functional group from other H-bond accepting functional
groups such as the corresponding alcohol. We note that the
actual percentages found here apply only to our sampling of
1053 cells which approaches nominal 1× coverage of the
≈1100 rat ORs. At this low level of coverage, some ORs were
likely not present, and some may occur more than once. The
time- and labor-intensive nature of live neuron screening makes
a higher sampling coverage impractical using current methods,
and the limited lifetime of the dissociated OSNs precludes the
testing of a larger group of compounds on a given OSN.
Dose−Response Curves in the Aldehyde-Specific
Receptor OR-I7. Though it is not possible to identify which
OR family member is expressed in each of the cells profiled in
Figure 2b, the data suggest that gem-diol recognition is
common among ORs specific for the aldehyde functional
group. Pharmacologically, the rodent OR-I7 is one of the most
thoroughly characterized ORs and has been found to have a
strict requirement for the aldehyde group in the context of
aliphatic chains with 6 to 11 carbons.30−32,36,37 To ask whether
OR-I7 detects the gem-diol form of the aldehyde, we probed the
mouse and rat OR-I7 with compounds 1−5. Both orthologs are
activated by octanal, though with some difference in the
preferred chain length.36,38 On the one hand, if OR-I7 is
activated by octanal’s carbonyl form, we would expect
compound 2 (>99% gem-diol) to be completely inactive. On
the other hand, if OR-I7 activation depends on the gem-diol, we
would expect 2 to be two- to 3-fold more potent than octanal,
due to the greater percentage of the gem-diol form, unless the
fluorines have an unfavorable steric or dipole effect. In one type
of experiment, we expressed recombinant mouse OR-I7 in
Hana3A cells,39−41 an OR heterologous expression system
based on HEK293T cells, and probed the cellular response
using an assay that responds directly to the cAMP second
messenger (Figure 3a, GloSensor Assay). The summed
Hana3A/mouse OR-I7 dose response curves are shown over
the 3 to 7.5 min time period in Figure 3A. Raw data for the
entire 30 min experiment is included in the Supporting
Information. Mouse OR-I7 was activated by octanal with an
EC50 of about 1.5 μM. Difluorooctanal 2 activated OR-I7, but
about 7-fold more weakly (EC50 ≈10 μM). The alcohols and,
notably, the other 2,2-disubstituted octanal, 3, did not
significantly activate mouse OR-I7. Compounds 1−3 were
also tested against the recombinant rat ortholog expressed in rat
OSNs with similar results (Figure 3b). Alcohol 5 is known not
to activate rat OR-I7.32 In addition, gem-diol 2 was tested
against the rat OR-I7 in Hana3A cells using the luciferase
reporter gene as an alternative readout system and was also
found to have an EC50 of ≈10 μM (not shown). These data
support the possibility that the gem-diol is required for
activation of this aldehyde-specific receptor, since the
corresponding primary alcohols were inactive. The 7-fold
lower potency of gem-diol 2 in comparison to octanal is subject
to interpretation. In view of our finding in the rat OSN survey
that substitution at C-2 is generally unfavorable for octanal
ORs, our interpretation is that the fluorines create opposing
steric and electronic effects: through their inductive effect, they
permit only the gem-diol form, which is favorable, but they are
sterically unfavorable, and so, compound 2 requires a higher
concentration for binding and activation. In compound 3, both
steric and electronic effects are unfavorable. Thus, the OR-I7
receptor appears to be activated by the octanal gem-diol and,
given the structural differences between the aldehyde and gem-
diol forms described in the Introduction, likely achieves its
aldehyde specificity through sensing the gem-diol form.
Figure 3. Dose−response curves for compounds 1−5 and rodent OR-I7. (a) Hana3A cells expressing mouse OR-I7 were exposed to odorants while
cAMP production was monitored over a 30 min period. The summed response between 3 and 7.5 min is shown versus odorant concentration. (b)
Rat olfactory sensory neurons infected with adenovirus expressing rat OR-I7 were assayed using calcium imaging during exposure to odorants 1−3.
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Homology Model of Rodent OR-I7 Docked with
Octane-1,1-Gem-Diol. To further evaluate the possibility
that rat and mouse OR-I7 might be activated by the gem-diol,
we modeled both orthologs with this form of the aldehyde
functional group.42 The only high resolution structural
information available for odorant receptors has come from
homology models, and many have been based on GPCRs
crystallized in their inactive form. While these models may
prove to be accurate for binding the unactivated ORs, they are
less likely to provide direct insight into how odorant ligands
stabilize the activated form of the OR to initiate signal
transduction. Our two new models are based on the recently
solved crystal structure of the activated, ligand-, and G-protein-
bound β2-adrenergic receptor (β2AR) (Pdb 3SN6).43 The two
ortholog models proved to be closely similar, and representa-
tive views of the rat OR-I7 model are presented in Figure 4. We
docked into the two models the gem-diol of a conformationally
restricted analog of octanal previously found to be as potent as
octanal against the rat OR-I731 and evaluated its accommoda-
tion in the binding site for the best scored poses (see Methods
for details). The more flexible octane-1,1-diol (or octanal in its
carbonyl form, see below) was then superposed on and
replaced the optimal pose of this ligand. In its most favorable
position (Figure 4a, rat OR-I7 model), the gem-diol ligand was
found tipping slightly down toward the intracellular side and
aiming the gem-diol at TM2 and TM7, while in some previous
models the ligand is found slightly higher within the membrane,
tipping toward the extracellular side, and aiming at TM4, where
it makes a possible contact with Lys164.18,23,24 In our model,
TM4 is further from the ligand. A side-view of octane-1,1-diol
(Figure 4b) shows the alkyl chain resides in a hydrophobic
pocket formed by TMs 3, 5, and 6 with the geminal hydroxyls
well oriented to interact through hydrogen bonds with Tyr74
(BW 2.53) and Tyr257 (BW 6.48) (Figure 4c). Interestingly,
Tyr257 may be stabilized by a hydrogen bond to Glu116 in
such a way as to position the Tyr257 hydroxyl oxygen to act as
hydrogen bond acceptor for the gem-diol. The carbonyl form of
octanal would be unable to interact with Tyr257 in this way, or
with both tyrosines simultaneously, which provides a
preliminary explanation for a more favorable interaction
between OR-I7 and the gem-diol of octanal compared to the
carbonyl form. Nevertheless, both gem-diol and aldehyde were
well accommodated in the binding pocket of the receptors, as
estimated by interaction energy calculations (rat I7, DS 3.5
Accelrys; mouse I7 DS 4.0, Accelrys). The values of interaction
energy with the rat OR-I7 (−18.12 kcal/mol for the gem-diol,
−12.05 kcal/mol for the carbonyl form), and the mouse OR-I7
(−7.4 kcal/mol for the gem-diol, −5.5 kcal/mol for the
carbonyl form) predict that the gem-diol is superior to the
aldehyde by ≈2−6 kcal/mol.
Since the carbonyl form of an aldehyde is more volatile than
the gem-diol, it is reasonable to expect that most of an aldehyde
sample reaching the nose through the air will initially be in the
carbonyl form. Aldehydes undergo rapid acid-25 and base-44
catalyzed hydration, but at the slightly acidic pH of the nasal
epithelium,45 the uncatalyzed rate of hydration is expected to
be slow (k ≈ 3.5 × 10−3 s−1, t1/2 = 3.3 min).
25 Although some
gem-diol will have formed within the time it takes to perceive an
aldehyde, without catalysis the equilibrium concentration will
not be achieved within that time. In our live OSN assay, where
the mucus is lost during OSN isolation, we avoided any
possible kinetic influence by equilibrating compounds 1−5 in
aqueous buffer prior to testing. However, in live animals, an
aldehyde hydratase activity might be necessary to meet a gem-
diol threshold concentration for some aldehyde ORs.
Interestingly, carbonic anhydrase, an enzyme known to catalyze
the hydration of aliphatic aldehydes46 is found in the nasal
mucus47 and, we speculate, might play a role in accelerating
gem-diol formation. Evidence supporting the enzymatic
conversion of odorants in the mucus has previously been
found.48 Phosphate and other solutes have also been found to
modestly accelerate aldehyde hydration.49 Since GPCRs can
harbor significant numbers of ordered water molecules50 and
are predicted to contain even more,51 some aldehyde ORs
might mediate aldehyde hydration themselves upon ligand
binding. Using simple acid−base catalysis, a mucus catalyst, or
the OR itself, might provide the modest rate enhancement
necessary to maximize gem-diol formation on the time scale of
olfaction.
In conclusion, our data suggest that a significant percentage
of aldehyde-specific ORs recognize this functional group
through its ability to engage in an equilibrium-based chemical
Figure 4. Homology model of rat OR-I7 based on the activated ß2-adrenergic receptor (pdb 3SN6) and bound to octane-1,1-diol. (a) Overall
structure showing OR-I7 with the octane-1,1-diol agonist aiming the gem-diol toward trans-membrane helices (TM) 2 and 7. TMs are colored from
blue (N-terminus) to red (C-terminus). Ligand membrane depth is shown in relation to TM4 (scale bar, 12.7 Å). (b) The octanal carbon chain is in
a hydrophobic pocket formed by TMs 3, 5, and 6. (c) Possible H-bond recognition of the gem-diol by Y74 and Y257. Carbons of octane-1,1-diol are
shown in yellow.
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transformation to a different functional group, the gem-diol. We
propose that this is one way that aldehyde-specific ORs
discriminate aldehydes from similar H-bond accepting func-
tional groups, allowing the OR to contribute unequivocal
aldehyde-specific information to the olfactory code.4
■ METHODS
Electrostatic Potential Maps. Models were constructed and
EPM calculations made using Spartan 10 V1.1.0 (Wavefunction, Inc.).
Chemical Synthesis and Characterization. See Supporting
Information.
Aldehyde Hydration Equilibrium 1H NMR Measurements.
Hexanal or difluoroheptanal (3 mg) was dissolved in 1 mL D2O. 64
transients were accumulated. For dimethylhexanal, ≈0.5 mg was used
because of its lower solubility in water, and 800 transients were
accumulated. Data acquisition was begun at least 15 min after
dissolving the compound in D2O.
Olfactory Sensory Neuron Preparation and Calcium Imag-
ing Recordings. All animal procedures were approved by the
Columbia University Institutional Animal Care and Use Committee
(IACUC) and performed at Columbia University in compliance with
relevant national guidelines and regulations.
Procedures for isolating rat OSNs31 and performing calcium
imaging recordings35 were done as previously described. Briefly,
dissociated cells were washed in rat Ringer’s solution and loaded in the
dark with Fura-2AM supplemented with pluronic acid in rat Ringer’s
solution for 45 min at room temperature (RT). Fluorescent recordings
were made at 380 nm excitation and 510 nm emission. In order to
minimize photobleaching, images were only taken every 4 s. The
coverslip was placed into a perfusion chamber (200 μL) that pumped
fresh rat Ringer’s solution over the cells at 2 mL min−1. Odorant
application consisted of injecting 400 μL of solution into the constant
perfusion stream over the course of 4 s.
Odorants were stored under argon gas at or under 4 °C and used
within 7 days of purification. Freshly made DMSO-odorant stocks
were diluted to 30 μM in rat Ringer’s solution31 (pH 7.4) and loaded
into stimulus syringes. The diluted odorants were prepared at least 1 h
prior to the start of imaging. Plain DMSO in Ringer’s solution at a
matched volume was applied as a control; the rare cells that responded
to vehicle alone were excluded from further study. Stimuli were given
at least 2 min apart to permit complete odorant clearance.
Data in Figure 2 are shown as the fractional change in fluorescent
light intensity, (F−F0)/F0, where F is the fluorescent light intensity at
each point and F0 is the value for the emitted fluorescent light at the
start of each CCD camera movie before the first stimulus application.
Responses were measured between the baseline and peak ΔF/F
change. To permit within-cell normalization of responses and to
correct for any baseline drift due to incomplete recovery or focus shift,
octanal applications were provided at the start or soon after the start of
compounds testing, and near or at the end. We previously established
that when a cell is challenged with three sequential identical stimuli,
the magnitude of the response to the second application meets or
exceeds 90% (0.90) that predicted from a trend line drawn between
the peak magnitudes of the first and third flanking applications. Using
this trend-line approach, we calculated the relative response of
odorants compared to the response to octanal in each cell by taking
the ratio of the measured response to the trend-line predicted
response. When a compound is more efficacious than octanal, these
ratios exceed 1.0.
At the end of each recording session, cells were challenged with 10
μM forskolin to activate adenylyl cyclase, a component of the signal
transduction cascade downstream of the OR. We take the response to
forskolin as an indicator that the cell is functionally intact. Only cells
that could respond to forskolin were included in Figure 2 data.
Calcium imaging dose response curves for compounds 1−5 against
the recombinant rat OR-I7 were done similarly, as previously
described,31,32 in rat OSNs expressing OR-I7 and GFP from an
adenovirus vector.37 For these experiments, 10 μM octanal, a
saturating concentration for rat OR-I7, was used as the flanking
stimulus to allow for normalization.
Mouse OR-I7 Hana3A GloSensor Assay. The GloSensor cAMP
Assay System (Promega) was used according to manufacturer’s
instructions with slight modifications. Briefly, a plasmid encoding Rho-
tagged mouse OR-I7 (80 ng/well) was transfected into the Hana3A
cell line in 96-well plate format along with plasmids encoding the
human receptor trafficking protein, RTP1S40 (10 ng/well), type 3
muscarinic acetylcholine receptor (M3-R)39 (10 ng/well), and
pGloSensorTM-22F (10 ng/well). Then, 18 to 24 h following
transfection, cells were loaded with 2% GloSensor reagent for 2 h and
treated with odorant compounds in a total volume of 74 μL.
Luminescence was measured using a Polarstar Optima plate reader
(BMG) with a time interval of 90 s per well. Raw data for the first 30
min is shown in Supporting Information. Data was analyzed and EC50s
estimated using Prism 5.0 and Microsoft Excel. Responses over t = 3−
7.5 min were summed, base-lined, normalized, and plotted vs odorant
concentration in Figure 3A.
Rat OR-I7 Hana3A Luciferase Assay (Compound 2 Only). The
Dual-Glo Luciferase Assay System (Promega) was used for the
luciferase assay as previously described.41 Briefly, a plasmid encoding
Rho-tagged rat OR-I7 (5 ng/well) was transfected into the Hana3A
cell line in 96-well plate format along with plasmids encoding the
human receptor trafficking protein, RTP1S40 (5 ng/well), pSV40-
Renilla (5 ng/well; Promega), CRE-luciferase (10 ng/well; Stra-
tagene), and type 3 muscarinic acetylcholine receptor (M3-R)39 (2.5
ng/well). Then, 18 to 24 h following transfection, cells were treated
with compound 2 for 4 h at 37 °C, as described.39 Luminescence was
measured using a Polarstar Optima plate reader (BMG). Luciferase
measurements were normalized to Renilla luciferase measurements to
control for transfection efficiency and cell viability. Fold change values
were calculated by the formula (F1−F0)/F0, where F1 is the normalized
luminescence response to the odorant and F0 is the normalized
luminescence when no odorant was applied. Data were analyzed and
the EC50 for 2 (≈10 μM) was estimated using Prism 5.0 and Microsoft
Excel. Estimating the EC50s for the other four odorants under the
conditions of this assay was not possible because they underwent
significant evaporation. For this reason, we used the GloSensor and
calcium imaging assays described above to monitor OR-I7 activation in
real time.
Homology Model Construction and Ligand Docking. The rat
OR-I7 (Uniprot entry: P23270) was aligned with the human β2-AR
sequence (3SN6.pdb) using TM Coffee (http://tcoffee.crg.cat/apps/
tcoffee/do:tmcoffee) and MAFFT (http://mafft.cbrc.jp/alignment/
server/). The manually refined alignment is shown in the Supporting
Information. A disulfide bond was maintained between Cys102 and
Cys184 as a restriction during model generation. A model of rat OR-I7
was created using the MODELER protocol in Discovery Studio 3.5
(DS3.5, Accelrys). The model was refined using minimization and
side-chain optimization using SCWRL (http://dunbrack.fccc.edu/
scwrl4). Trp154 (4.50) in OR-I7 was manually changed to a rotamer
most similar to the one in β2-AR. This rotamer also has the most
favorable energy. Before docking, the extracellular and intracellular
loops were removed and a binding site was created using ‘define and
edit binding site’ protocol (Discovery Studio 3.5, Accelrys). Ligands
were prepared using “prepare ligands” protocol and conformations
were generated using “generate conformations” protocol. To minimize
ligand flexibility during docking, the gem-diol form of the conforma-
tionally restricted octanal analog, trans-2-(4-ethylcyclohexyl)ethanal
was used in place of octane-1,1-diol. This aldehyde was previously
found to have about the same rat OR-I7 potency as octanal.31 Docking
of this ligand was performed using CDocker protocol (all protocols
available in Discovery Studio 3.5, Accelrys). Octane-1,1-diol was
superposed onto the optimal pose and used to replace the
conformationally restricted ligand, and the model was energy
minimized. An identical protocol was used to prepare a model of
the mouse OR-I7 ortholog (Uniprot entry: Q9QWU6) using
Discovery Studio 4.0 (DS4.0, Accelrys).
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